FOI Request
- Disclosure ID
- FOI/05123
- Request Date
- May 10, 2022
- Subject
- Contract Registar
- Description
1. How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2022:
- Aflibercept
- Bevacizumab
- Brolucizumab
- Dexamethasone
- Fluocinolone acetonide
- Ranibizumab
2. Please provide the number of injections/implants by eye condition for the four-month period from January to April 2022.
Number of Injections/Implants: Jan to Apr 2022
Eye Conditions
Treatment Wet Age-Related Macular Degeneration wAMD Diabetic Macular Degeneration DMO Retinal Vein Occulusion RVO
Aflibercept
Bevacizumab
Brolucizumab
Dexamethasone
Fluocinolone acetonide
Ranibizumab
- Response
Please see accompanying document